Am J Transplant, Volume 19, Suppl 3 Archives - Page 117 of 214 - ATC Abstracts

2019 American Transplant Congress
HbA1c as a Noninvasive Predictor of Chronic Histopathologic Changes in Living Donors for Kidney Transplantation
K. Tanaka¹, S. Nishida¹, K. Kinoshita¹, Y. Hidaka¹, M. Toyoda², A. Inadome³, A. Takeda⁴, H. Yokomizo⁵, S. Uekihara⁶, J. Shoji⁷, S. Yamanaga¹
¹Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ²general medicine, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ³Urology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan, ⁴Nephrology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan, ⁵Surgery, Japanese Red Cross Kumamoto Hospital, kumamoto, Japan, ⁶general medicine, Japanese Red Cross Kumamoto Hospital, kumamoto, Japan, ⁷Nephrology, UCSF Connie Frank Transplant Center, San francisco, CA
*Purpose: The degree of chronic histopathologic changes in renal allografts, including interstitial fibrosis, tubular atrophy, and arteriolar hyalinosis, can have clinical implications in long-term allograft…
2019 American Transplant Congress
Patients With Biliary Complications Following Orthotopic Liver Transplantation Can Be Successfully Managed By Serial Endoscopic Retrograde Cholangio-pancreatography
R. Kaur, I. C. Morales, D. Dhillon, M. S. Ilias, S. Nagai, D. Venkat, A. Yoshida, S. Jafri
Henry Ford Hospital, Detroit, MI
*Purpose: We evaluated the quality of endoscopic intervention for biliary complications after liver transplantation in a diverse urban center.*Methods: A retrospective chart review of liver…
2019 American Transplant Congress
Osmotic Demyelination Syndrome after Liver Transplantation- Etiology and Treatment Options
P. Mihaylov¹, D. Soma², D. Kuruppu², B. Ekser², R. Mangus², J. Fridell², R. Snook², C. Kubal²
¹Indiana Univ School of Medicine, Pavia University School of Medicine, Indianapolis, IN, ²Indiana Univ School of Medicine, Indianapolis, IN
*Purpose: Orthotopic liver transplantation (OLT) is the only effective therapy for patients with end stage liver failure that increases long-term survival, but is not without…
2019 American Transplant Congress
Risk Factors for Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation. An Analysis of UNOS Registry
T. Kitajima, S. Nagai, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The Model for End-Stage Liver Disease (MELD) score has been used for predicting waitlist outcomes in patients with cirrhosis. However, the post-transplant prognostic value…
2019 American Transplant Congress
Meld Score / Grwr Ratio (meldgr) Can Predict Surgical Outcomes And Prognosis Of The Recipients In Adult-to-adult Living Donor Liver Transplantation
A. Tanemura, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji
Hepatobiliary Pancreatic and Transplant Surgery, Mie University, Tsu, Japan
*Purpose: In living donor liver transplantation (LDLT), various risk factors have been identified among both recipient and donor factors, such as Model for End-Stage Liver…
2019 American Transplant Congress
Effects of Thalidomide and Dexamethasone Co-Treatment on CD8⁺ T Cells
J. Kim¹, E. Kim², Y. Cho¹, H. Lee¹, M. Kim³, Y. Kim³, K. Huh³, B. Kim⁴
¹The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Transplantation Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁴Nephrology Division, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Thalidomide (TM) is known to have anti-cancer and anti-inflammatory effects and dexamethasone (DX) has been reported that it also reduces inflammation and inhibits inflammatory…
2019 American Transplant Congress
Inhibition of CXCR3 Expression through Blockade of STAT3 Alpha Signaling Down-Regulate Inflammation of Renal Ischemia-Reperfusion Injury
J. Kim¹, J. Park², K. Yoo², J. Moon¹, J. Jeong¹, C. Lee³, Y. Kim¹, S. Yang⁴
¹Seoul National University College of Medicine, Seoul, Korea, Republic of, ²Dongguk University College of Medicine, Gyeonggi-do, Korea, Republic of, ³Cheju Halla General Hospital, Cheju, Jeju-do, Korea, Republic of, ⁴Kidney Research Institute, Seoul National University, Seoul, Korea, Republic of
*Purpose: Signal transducer and activator of transcription 3 (STAT3) is the main mediator of interleukin 6 (IL-6)-type cytokine signaling. Although it exists in two isoforms:…
2019 American Transplant Congress
Characterization Of Microscopic Hematuria Following Renal Transplant
M. L. McDonald¹, T. N. Duong², N. Datta², H. A. Gritsch¹, S. Bunnapradist²
¹Department of Urology, Kidney and Pancreas Transplant Programs, UCLA, Los Angeles, CA, ²Division of Nephrology, Kidney and Pancreas Programs, UCLA, Los Angeles, CA
*Purpose: The American Urological Association (AUA) recommends a CT Urography and cystoscopy for the evaluation of a single episode of microscopic hematuria (MH) in the…
2019 American Transplant Congress
Contemporary Predictors and Impact on Survival of Early Readmission after Kidney Transplant: Analysis of the Nationwide Readmission Database
N. Elfadawy, N. Tashtish, S. Al-kindi, D. Hricik, E. Sanchez, N. Sarabu
University hospitals of Cleveland, Cleveland, OH
*Purpose: Thirty-day readmissions after kidney transplantation are common and contribute to healthcare utilization and costs. We sought to describe the rates, causes, and predictors for…
2019 American Transplant Congress
Effects of Co-Morbidities on Kidney Transplantation Outcome in South Korea: A Nationwide-Population Based Study
M. Yu¹, S. Park², J. Moon², J. Jeong², J. Kim², Y. Kim², K. Han³, Y. Kim², H. Lee²
¹Hanyang University Guri Hospital, Guri, Korea, Republic of, ²Seoul National University Hospital, Seoul, Korea, Republic of, ³College of Medicine, Catholic University, Seoul, Korea, Republic of
*Purpose: Kidney transplantation (KT) has become the most effective treatment for end stage renal disease. Improvement of general medical care as well as immunosuppressive agents…